| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/01/2006 | CN1854308A Basic groups series testing method |
| 11/01/2006 | CN1854287A Assay systems, kits and methods for detecting microorganisms |
| 11/01/2006 | CN1853734A Integrator system and method for rapidly determining effectiveness of a germicidal treatment |
| 11/01/2006 | CN1282750C FQ-PCR diagnosis kit of WSSV and test method |
| 11/01/2006 | CN1282741C 核酸扩增方法 Nucleic acid amplification method |
| 10/31/2006 | US7130746 Computer systems and computer programs for determining protein activity levels using gene expression profiles |
| 10/31/2006 | US7129345 Keto-substituted steroid compounds |
| 10/31/2006 | US7129344 Nucleic acid isolation |
| 10/31/2006 | US7129342 Infectious cDNA clone of GB virus B and uses thereof |
| 10/31/2006 | US7129341 Identification of Candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
| 10/31/2006 | US7129308 Functionalized silicon compounds and methods for their synthesis and use |
| 10/31/2006 | US7129307 Functionalized silicon compounds and methods for their synthesis and use |
| 10/31/2006 | US7129267 Methods for SHP1 mediated neuroprotection |
| 10/31/2006 | US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 10/31/2006 | US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 10/31/2006 | US7129212 Transformation of plant cell with nucleotide sequences coding bacillus insecticidal protein generating insect resistant plants; biological pest control |
| 10/31/2006 | US7129207 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders |
| 10/31/2006 | US7129085 Polynucleotides encoding a human leucine-rich repeat domain containing protein, HLLRCR-1 |
| 10/31/2006 | US7129081 Microarray apparatus for monitoring and screening biological activity, especially metabolism and/or reproduction of bacteria, fungi and cells |
| 10/31/2006 | US7129080 Vitro model of priocidal activity |
| 10/31/2006 | US7129077 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder |
| 10/31/2006 | US7129075 Isolated CEL II endonuclease |
| 10/31/2006 | US7129074 Nucleoside triphosphate diphosphohydrolase (NTPDase 8) and uses thereof |
| 10/31/2006 | US7129073 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 10/31/2006 | US7129070 Targeted system for removing tumor cells from cell populations |
| 10/31/2006 | US7129062 Matrix attachment regions and methods for use thereof |
| 10/31/2006 | US7129057 Human testis specific serine/threonine kinase 3 |
| 10/31/2006 | US7129056 Detecting circulating epithelial cancer cells in anticoagulated whole blood sample by using special transparent container, mixing sample with epitope labeling agents/cell morphology stains, centrifuging, and inspecting |
| 10/31/2006 | US7129051 Tissue analysis and kits therefor |
| 10/31/2006 | US7129050 Method for distinguishing different-sequence polynucleotides |
| 10/31/2006 | US7129049 detecting the presence of a biomarker; presence of A nucleotides at nucleotide 102 in both alleles is indicative of the horse being predisposed to or has GSD IV |
| 10/31/2006 | US7129048 Identifying preferential nucleotide sequences using coded microcrystal microarrays; gene pattern expression analysis; semiconductors and bioassays |
| 10/31/2006 | US7129047 Gold bonded to Dna as detector; measuring fluorescence; concave, convex pattern on surface |
| 10/31/2006 | US7129046 Linking to chemical array assemblies with metal layers |
| 10/31/2006 | US7129045 Methods of detecting polynucleotide kinase and its use as a label |
| 10/31/2006 | US7129044 Renaturation, reassociation, association and hybridization of nucleic acid molecules |
| 10/31/2006 | US7129043 upregulation of the CLN3 gene in subject identifies the subject as having an increased risk of developing colon cancer |
| 10/31/2006 | US7129042 Compositions and methods for detecting severe acute respiratory syndrome coronavirus |
| 10/31/2006 | US7129041 Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome |
| 10/31/2006 | US7129040 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 10/31/2006 | US7129039 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| 10/31/2006 | US7129038 Using permeable sheets for monitoring and measuring glucose, cholesterol, protein and/or phenylalanine concentrations in bodily fluids; colorimetric analysis |
| 10/31/2006 | US7129037 Delivering antigen to dendritic cells by contacting dendritic cells with apopototic cells expressing an antigen to allow antigen to be internalized by the dendritic cells, and wherein apoptotic cells have been induced in vitro to become apoptotic |
| 10/31/2006 | US7129036 Reporter molecules and methods for assaying the lipidations status of a cell |
| 10/31/2006 | US7128920 Isolated polypeptide and polynucleotide of given sequence; diagnosing or prognosing a disease by determining the presence or absence of a mutation in gene; Streptococcus pneumoniae |
| 10/31/2006 | US7128904 Material containing metal ion ligand complex producing nitric oxide in contact with blood |
| 10/31/2006 | US7128877 Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer |
| 10/31/2006 | CA2293819C A method for in vitro molecular evolution of protein function |
| 10/31/2006 | CA2256545C Probe for analysis of nucleic acids |
| 10/31/2006 | CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 10/31/2006 | CA2179012C Molecular diagnosis of familial adenomatous polyposis |
| 10/31/2006 | CA2173862C Apparatus and method for transfer of a fluid sample |
| 10/31/2006 | CA2162677C Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 10/31/2006 | CA2129733C Mammalian expression systems for hcv proteins |
| 10/28/2006 | CA2545188A1 Electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes |
| 10/28/2006 | CA2545179A1 Method for manufacturing an electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes |
| 10/28/2006 | CA2544997A1 Immobilized biological material with improved functionality and method for producing the same |
| 10/26/2006 | WO2006113931A2 Microarray-based single nucleotide polymorphism, sequencing, and gene expression assay method |
| 10/26/2006 | WO2006113930A2 Device for rapid detection and identification of single microoganisms without preliminary growth |
| 10/26/2006 | WO2006113833A2 Metallothionein as an early biomarker for death secondary to septic shock and as a novel therapeutic target for septic shock |
| 10/26/2006 | WO2006113808A2 Methods of making and modifying porous devices for biomedical applications |
| 10/26/2006 | WO2006113785A2 Laser modification and functionalization of substrates |
| 10/26/2006 | WO2006113770A1 A method for providing dna fragments derived from a remote sample |
| 10/26/2006 | WO2006113766A2 Methods for diagnosing treating neuroendocrine cancer |
| 10/26/2006 | WO2006113728A2 Inhibiting biofilm formation |
| 10/26/2006 | WO2006113710A2 Luminescent atp detection with extended linearity |
| 10/26/2006 | WO2006113706A2 Increased sensitivity of nucleic acid-based detection of organisms by fractionation of target genomes |
| 10/26/2006 | WO2006113678A2 Methylation markers for diagnosis and treatment of cancers |
| 10/26/2006 | WO2006113671A2 Methylation markers for diagnosis and treatment of cancers |
| 10/26/2006 | WO2006113613A1 5′/3′ ratioing procedure for detection of gene rearrangements |
| 10/26/2006 | WO2006113610A2 Rapid exchange luminescence (rel) for high sensitivity detection |
| 10/26/2006 | WO2006113590A2 Flow-cytometric heteroduplex analysis for detection of genetic alterations |
| 10/26/2006 | WO2006113550A2 Viral nucleoprotein detection using an ion channel switch biosensor |
| 10/26/2006 | WO2006113529A2 Diagnosis of sepsis |
| 10/26/2006 | WO2006113522A2 Methods of detecting hepatitis c virus |
| 10/26/2006 | WO2006113466A2 Methods and nucleic acids for analyses of cellular proliferative disorders |
| 10/26/2006 | WO2006113422A2 Human sweet and umami taste receptor variants |
| 10/26/2006 | WO2006113367A2 Methods, compounds and compositions with genotype selective anticancer activity |
| 10/26/2006 | WO2006113359A2 Packed bed for nucleic acid capture and amplification |
| 10/26/2006 | WO2006113210A2 Diagnostic multimarker serological profiling |
| 10/26/2006 | WO2006113198A2 Methods of enhancing isolation of rna from biological samples |
| 10/26/2006 | WO2006113095A2 Methods for diagnosing a bipolar disorder and attention-deficit/hyperactivity disorder |
| 10/26/2006 | WO2006112951A2 Method of risk management for patients undergoing natalizumab treatment |
| 10/26/2006 | WO2006112939A2 Compositions, methods, and kits for analyzing dna methylation |
| 10/26/2006 | WO2006112928A2 Method of analyzing cell structures and their components |
| 10/26/2006 | WO2006112879A2 Hunk, a snf1-related kinase essential for mammary tumor metastasis |
| 10/26/2006 | WO2006112867A2 Microarray gene expression profiling in classes of papillary renal cell carcinoma |
| 10/26/2006 | WO2006112818A2 3' modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and applications thereof as primers or probes |
| 10/26/2006 | WO2006112780A1 Method for amplification |
| 10/26/2006 | WO2006112733A1 Analysing breath samples for volatile organic compound |
| 10/26/2006 | WO2006112513A1 Method and composition to evaluate cytochrome p450 2d6 isoenzyme activity using a breath test |
| 10/26/2006 | WO2006112483A1 Diagnostic method and prognostic method for disease type of diffuse large b-cell lymphoma |
| 10/26/2006 | WO2006112461A1 Reagent for detection of bacterium alicyclobacillus acidoterrestris, culture medium for the detection and method for the detection |
| 10/26/2006 | WO2006112456A1 Perkinson disease-related gene grk5 and use thereof |
| 10/26/2006 | WO2006112418A1 Screening system for substance inhibiting inflammatory change of adipocyte and screening method using the same |
| 10/26/2006 | WO2006112401A1 Composition for treatment of cancer |
| 10/26/2006 | WO2006112400A1 Method of examining metastatic property and infiltration ability of cancer |
| 10/26/2006 | WO2006112238A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 10/26/2006 | WO2006112141A1 Method of base determination and base determination kit |